Chemours (CC) Change in Accured Expenses (2014 - 2026)

Chemours' Change in Accured Expenses history runs 13 years deep, the most recent figure standing at $12.0 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 340.0% year-over-year to $12.0 million; the TTM figure through Mar 2026 stood at $14.0 million (up 102.26% YoY), while the FY2025 annual figure was -$3.0 million, up 99.55% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $12.0 million, up from -$95.0 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $660.0 million in Q3 2023, with the low at -$644.0 million in Q2 2024.
• The 5-year median for Change in Accured Expenses is -$5.0 million (2025), against an average of -$3.7 million.
• The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses jumped 633.33% in 2023, then slumped 163.89% in 2025.
• Chemours' Change in Accured Expenses stood at -$319.0 million in 2022, then surged by 94.36% to -$18.0 million in 2023, then sank by 100.0% to -$36.0 million in 2024, then plunged by 163.89% to -$95.0 million in 2025, then jumped by 112.63% to $12.0 million in 2026.
• Business Quant data shows CC's Change in Accured Expenses at $12.0 million in Q1 2026, -$95.0 million in Q4 2025, and $22.0 million in Q3 2025.